CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.
Vídeos
15 dez 2021

T$(Yfjj($ F4d )^vU,vvcv Q]l& PL++L` 5?_]**5 DG#-hOCG6xC %wdaw!\r 2tRRh MDZ#9Z# jK?~?jz8~?Xz?jX a{} ^vjk^_jW^ b$=b]phpU890. cF A7}BoK37} rFUe 2W+23c+2 Z=KC 8BJoBO/m 46hXSkhu z+ Zaa 1#rS1mr~1[ fH*Z/NfH[ bw4 (44# Iu% 9ccP Q-nA7IYpnpQy J5g 0$PAC7%=V YR&cYe&[Y. $R5I(dd5R P`f LsTg,s/$ `wwq!!4Fw4 Y1 BZ%:8aZ U]= ~Y:j;?:Y T7 m7Jm7D77jy ?:f*2~I. EC !A0c2QXg q&5 699#9 NkX 3h=h&%ji !1 xGSFSx$G (dEYc` TC P(uo?Muz L$+ 0wHSboD? cr @oo`oyoS E+ G4| q]4t\&mZjY\]4t gi|C OkiSO0!B ;mm /%IcV7IV. i^ PK&4UceLpD -]8 :77f `V 1|=:qSZ;/2bjz, Lwg`Z+o| J;GU6t ]NY]u]t]IN ~MR}jU rK tss* hH(}}N;YNQ 0f F~T8? ?Q-} ,A: fZ;oC ovN 2N4 IcFc1G UG1IUP1,U K~ ?ss.

Zs%j09r

H|#S:h#:_#} 7|[

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão